DOXORUBICIN Teva 50 mg/25ml flac 25 ml
7680593500038
CH-59350
L01DB01
07.16.1.
1 / 2
google
Details
- Product number
- 5935003
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- doxorubicini hydrochloridum 50 mg, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 25 ml corresp. natrium 88.79 mg.
Articles (1)
Doxorubicin-Teva 50 mg/25 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
88.79 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 76.60
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2010
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 59350
- Drug name
- Doxorubicin-Teva, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/12/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOXORUBICIN Teva 50 mg/25ml flac 25 ml
- Description (DE)
- DOXORUBICIN Teva 50 mg/25ml Durchstf 25 ml
- Market launch
- 02/12/2009
- Narcotic (BTM)
- No